- Joined
- Apr 21, 2011
- Messages
- 3,604
- Reaction score
- 9,211
I've typically requested that patients come off Dilantin prior to any cranial radiation due to risk EMPACT (eythema multiforme).
Hypothetical Glioma patient on Keppra and Dilantin and the Neuro Onc refuses to remove the Dilantin during radiation. What is your course of action? Do you treat regardless or refuse to treat?
Hypothetical Glioma patient on Keppra and Dilantin and the Neuro Onc refuses to remove the Dilantin during radiation. What is your course of action? Do you treat regardless or refuse to treat?